Ticker

VRDN

Viridian Therapeutics, Inc.

9 catalysts on file

VRDN

Viridian Therapeutics, Inc.

Phase 3 Confirmed

elegrobart

thyroid eye disease (TED)

63d ago May 5, 2026

SEC 8-K verified 15h ago

Countdown card →

VRDN

Viridian Therapeutics, Inc.

Approval Confirmed

Lumvoa

thyroid eye disease

8d ago Jun 29, 2026

SEC 8-K verified 14h ago

Countdown card →

VRDN

Viridian Therapeutics, Inc.

PDUFA Confirmed

veligrotug

thyroid eye disease (TED)

7d ago Jun 30, 2026

SEC 8-K verified 15h ago

Countdown card →

VRDN

Viridian Therapeutics, Inc.

Phase 3 Confirmed

elegrobart (VRDN-003)

active TED

7d ago ~ Jun 30, 2026

SEC 8-K verified 15h ago

Countdown card →

VRDN

Viridian Therapeutics, Inc.

Phase 1 Confirmed

VRDN-008

T-minus 177 days ~ Dec 31, 2026

SEC 8-K verified 15h ago

Countdown card →

VRDN

Viridian Therapeutics, Inc.

Catalyst Confirmed

TSHR program

thyroid eye disease (TED) and Graves’ disease

T-minus 177 days ~ Dec 31, 2026

SEC 8-K verified 15h ago

Countdown card →

VRDN

Viridian Therapeutics, Inc.

Catalyst AI-extracted

Undisclosed program

T-minus 177 days ~ Dec 31, 2026

SEC 8-K verified 15h ago

Countdown card →

VRDN

Viridian Therapeutics, Inc.

Catalyst Confirmed

elegrobart

thyroid eye disease (TED)

T-minus 267 days ~ Mar 31, 2027

SEC 8-K verified 15h ago

Countdown card →

VRDN

Viridian Therapeutics, Inc.

Phase 3 Confirmed

Lumvoa

thyroid eye disease

Date TBD Date TBD

SEC 8-K verified 14h ago

Countdown card →